Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Stakeholders' feedback on the proposed recommendations for updating the patented medicine prices review board (pmprb) budget impact analysis guidelines.

Foroutan N, Tarride JE, Xie F, Jameel B, Mills F, Levine M.

J Popul Ther Clin Pharmacol. 2020 Jan 3;27(1):e1-e24. doi: 10.15586/jptcp.v27i1.651.

PMID:
31922700
2.

Incremental healthcare utilisation and costs among new senior high-cost users in Ontario, Canada: a retrospective matched cohort study.

Muratov S, Lee J, Holbrook A, Guertin JR, Mbuagbaw L, Paterson JM, Gomes T, Pequeno P, Tarride JE.

BMJ Open. 2019 Oct 28;9(10):e028637. doi: 10.1136/bmjopen-2018-028637.

3.

A Canadian cost-effectiveness analysis of SAPIEN 3 transcatheter aortic valve implantation compared with surgery, in intermediate and high-risk severe aortic stenosis patients.

Tarride JE, Luong T, Goodall G, Burke N, Blackhouse G.

Clinicoecon Outcomes Res. 2019 Jul 29;11:477-486. doi: 10.2147/CEOR.S208107. eCollection 2019.

4.

Unplanned index hospital admissions among new older high-cost health care users in Ontario: a population-based matched cohort study.

Muratov S, Lee J, Holbrook A, Paterson JM, Guertin JR, Mbuagbaw L, Gomes T, Khuu W, Pequeno P, Tarride JE.

CMAJ Open. 2019 Aug 25;7(3):E537-E545. doi: 10.9778/cmajo.20180185. Print 2019 Jul-Sep.

5.

Electronic referral systems in health care: a scoping review.

Azamar-Alonso A, Costa AP, Huebner LA, Tarride JE.

Clinicoecon Outcomes Res. 2019 May 6;11:325-333. doi: 10.2147/CEOR.S195597. eCollection 2019. Review.

6.

The hidden cost of an extensive preoperative work-up: predictors of attrition after referral for bariatric surgery in a universal healthcare system.

Doumouras AG, Lee Y, Babe G, Gmora S, Tarride JE, Hong D, Anvari M.

Surg Endosc. 2020 Feb;34(2):988-995. doi: 10.1007/s00464-019-06894-9. Epub 2019 Jun 12.

PMID:
31190227
7.

A Comparison of Pharmaceutical Budget Impact Analysis (BIA) Recommendations Amongst the Canadian Patented Medicine Prices Review Board (PMPRB), Public and Private Payers.

Foroutan N, Tarride JE, Xie F, Mills F, Levine M.

Pharmacoecon Open. 2019 Dec;3(4):437-451. doi: 10.1007/s41669-019-0139-y. Review.

8.

Multicentre pilot randomised clinical trial of early in-bed cycle ergometry with ventilated patients.

Kho ME, Molloy AJ, Clarke FJ, Reid JC, Herridge MS, Karachi T, Rochwerg B, Fox-Robichaud AE, Seely AJ, Mathur S, Lo V, Burns KE, Ball IM, Pellizzari JR, Tarride JE, Rudkowski JC, Koo K, Heels-Ansdell D, Cook DJ.

BMJ Open Respir Res. 2019 Feb 18;6(1):e000383. doi: 10.1136/bmjresp-2018-000383. eCollection 2019.

9.

Use, costs, and predictors of psychiatric healthcare services following an autism spectrum diagnosis: Population-based cohort study.

Croteau C, Mottron L, Dorais M, Tarride JE, Perreault S.

Autism. 2019 Nov;23(8):2020-2030. doi: 10.1177/1362361319840229. Epub 2019 Apr 4.

PMID:
30943759
10.

Safety and efficacy of active and passive immunotherapy in mild-to-moderate Alzheimer's disease: A systematic review and network meta-analysis.

Foroutan N, Hopkins RB, Tarride JE, Florez ID, Levine M.

Clin Invest Med. 2019 Mar 23;42(1):E53-E65. doi: 10.25011/cim.v42i1.32393.

PMID:
30904037
11.

Impact of Psychoactive Drug Use on Developing Obesity among Children and Adolescents with Autism Spectrum Diagnosis: A Nested Case-Control Study.

Croteau C, Ben Amor L, Ilies D, Mottron L, Tarride JE, Dorais M, Perreault S.

Child Obes. 2019 Feb/Mar;15(2):131-141. doi: 10.1089/chi.2018.0170. Epub 2019 Jan 22.

PMID:
30668140
12.

A methodological review of national and transnational pharmaceutical budget impact analysis guidelines for new drug submissions.

Foroutan N, Tarride JE, Xie F, Levine M.

Clinicoecon Outcomes Res. 2018 Nov 26;10:821-854. doi: 10.2147/CEOR.S178825. eCollection 2018. Review.

13.

Just how much does it cost? A cost study of chronic pain following cardiac surgery.

Guertin JR, Pagé MG, Tarride JÉ, Talbot D, Watt-Watson J, Choinière M.

J Pain Res. 2018 Nov 8;11:2741-2759. doi: 10.2147/JPR.S175090. eCollection 2018.

14.
15.

Descriptive analysis of pharmacy services provided after community pharmacy screening.

Lancaster K, Thabane L, Tarride JE, Agarwal G, Healey JS, Sandhu R, Dolovich L.

Int J Clin Pharm. 2018 Dec;40(6):1577-1586. doi: 10.1007/s11096-018-0742-5. Epub 2018 Nov 26.

16.

Regional variation in healthcare spending and mortality among senior high-cost healthcare users in Ontario, Canada: a retrospective matched cohort study.

Muratov S, Lee J, Holbrook A, Costa A, Paterson JM, Guertin JR, Mbuagbaw L, Gomes T, Khuu W, Tarride JE.

BMC Geriatr. 2018 Nov 1;18(1):262. doi: 10.1186/s12877-018-0952-7.

17.

Is Screening for Atrial Fibrillation in Canadian Family Practices Cost-Effective in Patients 65 Years and Older?

Tarride JE, Quinn FR, Blackhouse G, Sandhu RK, Burke N, Gladstone DJ, Ivers NM, Dolovich L, Thornton A, Nakamya J, Ramasundarahettige C, Frydrych PA, Henein S, Ng K, Congdon V, Birtwhistle RV, Ward R, Healey JS.

Can J Cardiol. 2018 Nov;34(11):1522-1525. doi: 10.1016/j.cjca.2018.05.016. Epub 2018 Jun 21.

18.

Direct Health-Care Costs and Productivity Costs Associated With Hypoglycemia in Adults With Type 1 and Type 2 Diabetes Mellitus That Participated in the Canadian Hypoglycemia Assessment Tool Program.

O'Reilly DJ, Burke N, Tarride JE, Hahn J, Nurkanovic L.

Can J Diabetes. 2018 Dec;42(6):659-663. doi: 10.1016/j.jcjd.2018.01.010. Epub 2018 Jan 31.

PMID:
29885881
19.

Effectiveness of a Type 2 Diabetes Screening Intervention in the Canadian Workplace.

Tarride JE, Smofsky A, Nykoliation P, Allain S, Lewis-Daly L, Satok D, Schwartz J, Pollack JH, Guertin JR, McIntyre RS.

Can J Diabetes. 2018 Oct;42(5):493-499.e1. doi: 10.1016/j.jcjd.2017.12.008. Epub 2017 Dec 18.

20.

Clinical and economic burden of idiopathic pulmonary fibrosis in Quebec, Canada.

Tarride JE, Hopkins RB, Burke N, Guertin JR, O'Reilly D, Fell CD, Dion G, Kolb M.

Clinicoecon Outcomes Res. 2018 Feb 22;10:127-137. doi: 10.2147/CEOR.S154323. eCollection 2018.

21.

Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada.

Ball G, Xie F, Tarride JE.

Pharmacoecon Open. 2018 Mar;2(1):19-29. doi: 10.1007/s41669-017-0030-7.

22.

Age- and sex-specific Canadian utility norms, based on the 2013-2014 Canadian Community Health Survey.

Guertin JR, Feeny D, Tarride JE.

CMAJ. 2018 Feb 12;190(6):E155-E161. doi: 10.1503/cmaj.170317.

23.

Managing High-Cost Healthcare Users: The International Search for Effective Evidence-Supported Strategies.

Lee JY, Muratov S, Tarride JE, Holbrook AM.

J Am Geriatr Soc. 2018 May;66(5):1002-1008. doi: 10.1111/jgs.15257. Epub 2018 Feb 10.

PMID:
29427509
24.

Senior high-cost healthcare users' resource utilization and outcomes: a protocol of a retrospective matched cohort study in Canada.

Muratov S, Lee J, Holbrook A, Paterson JM, Guertin JR, Mbuagbaw L, Gomes T, Khuu W, Pequeno P, Costa AP, Tarride JE.

BMJ Open. 2017 Dec 26;7(12):e018488. doi: 10.1136/bmjopen-2017-018488.

25.

Low-intensity pulsed ultrasound for treatment of tibial fractures: an economic evaluation of the TRUST study.

Tarride JE, Hopkins RB, Blackhouse G, Burke N, Bhandari M, Johal H, Guyatt GH, Busse JW.

Bone Joint J. 2017 Nov;99-B(11):1526-1532. doi: 10.1302/0301-620X.99B11.BJJ-2017-0737.

PMID:
29092994
26.

Cognitive Impairment Mediates Workplace Impairment in Adults With Type 2 Diabetes Mellitus: Results From the Motivaction Study.

Lee Y, Smofsky A, Nykoliation P, Allain SJ, Lewis-Daly L, Schwartz J, Pollack JH, Tarride JE, McIntyre RS.

Can J Diabetes. 2018 Jun;42(3):289-295. doi: 10.1016/j.jcjd.2017.06.013. Epub 2017 Sep 25.

PMID:
28958785
27.

Increase in Psychoactive Drug Prescriptions in the Years Following Autism Spectrum Diagnosis: A Population-Based Cohort Study.

Croteau C, Mottron L, Presse N, Tarride JE, Dorais M, Perreault S.

J Popul Ther Clin Pharmacol. 2017 Aug 18;24(3):e19-e32. doi: 10.22374/1710-6222.24.3.2.

PMID:
28873291
28.

Preliminary Results of the Adoption and Application of the Integrated Comprehensive Care Bundle Care Program When Treating Patients with Chronic Obstructive Pulmonary Disease.

Guertin JR, Bowen JM, Gosse C, Blackhouse G, O'Reilly DJ, Baltaga E, Cox G, Johnson D, Le Blanc B, Loncke J, Pugsley S, Sivakumaran R, Wheatley L, Smith K, Tarride JE.

Can Respir J. 2017;2017:7049483. doi: 10.1155/2017/7049483. Epub 2017 Aug 7.

29.

Screening for atrial fibrillation in Canadian pharmacies: an economic evaluation.

Tarride JE, Dolovich L, Blackhouse G, Guertin JR, Burke N, Manja V, Grinvalds A, Lim T, Healey JS, Sandhu RK.

CMAJ Open. 2017 Aug 22;5(3):E653-E661. doi: 10.9778/cmajo.20170042.

30.

What Influences the Cost Effectiveness of Dabigatran versus Warfarin for Stroke Prevention in Atrial Fibrillation: A Systematic Review.

Jegathisawaran J, Holbrook A, Bowen JM, Burke N, Campbell K, Tarride JE.

J Popul Ther Clin Pharmacol. 2017 May 2;24(2):e1-e20. doi: 10.22374/1710-6222.24.2.1710. Review.

PMID:
28594478
31.

Illustration of the Impact of Unmeasured Confounding Within an Economic Evaluation Based on Nonrandomized Data.

Guertin JR, Bowen JM, De Rose G, O'Reilly DJ, Tarride JE.

MDM Policy Pract. 2017 Mar 16;2(1):2381468317697711. doi: 10.1177/2381468317697711. eCollection 2017 Jan-Jun.

32.

Erratum to: The Effect of Bariatric Surgery on Mobility, Health-Related Quality of Life, Healthcare Resource Utilization, and Employment Status.

Tarride JE, Breau R, Sharma AM, Hong D, Gmora S, Guertin JR, O'Reilly D, Xie F, Anvari M.

Obes Surg. 2017 Apr;27(4):1128. doi: 10.1007/s11695-017-2598-5. No abstract available.

PMID:
28194653
33.

Correction: Summary of Glaucoma Diagnostic Testing Accuracy: An Evidence-Based Meta-Analysis.

Ahmed S, Khan Z, Si F, Mao A, Pan I, Yazdi F, Tsertsvadze A, Hutnik C, Moher D, Tingey D, Trope GE, Damji KF, Tarride JE, Goeree R, Akhtar O, Hodge W.

J Clin Med Res. 2017 Mar;9(3):231. doi: 10.14740/jocmr2643wc1. Epub 2017 Jan 25.

34.

Summary of Glaucoma Diagnostic Testing Accuracy: An Evidence-Based Meta-Analysis.

Ahmed S, Khan Z, Si F, Mao A, Pan I, Yazdi F, Tsertsvadze A, Hutnik C, Moher D, Tingey D, Trope GE, Damji KF, Tarride JE, Goeree R, Hodge W.

J Clin Med Res. 2016 Sep;8(9):641-9. doi: 10.14740/jocmr2643w. Epub 2016 Jul 30. Erratum in: J Clin Med Res. 2017 Mar;9(3):231.

35.

The Effect of Bariatric Surgery on Mobility, Health-Related Quality of Life, Healthcare Resource Utilization, and Employment Status.

Tarride JE, Breau R, Sharma AM, Hong D, Gmora S, Guertin JR, O'Reilly D, Xie F, Anvari M.

Obes Surg. 2017 Feb;27(2):349-356. doi: 10.1007/s11695-016-2298-6. Erratum in: Obes Surg. 2017 Apr;27(4):1128.

PMID:
27503212
36.

A comparison of health utility scores calculated using United Kingdom and Canadian preference weights in persons with alzheimer's disease and their caregivers.

Fang M, Oremus M, Tarride JE, Raina P; Canadian Willingness-to-pay Study Group.

Health Qual Life Outcomes. 2016 Jul 18;14(1):105. doi: 10.1186/s12955-016-0510-y.

37.

Steps toward improving ethical evaluation in health technology assessment: a proposed framework.

Assasi N, Tarride JE, O'Reilly D, Schwartz L.

BMC Med Ethics. 2016 Jun 6;17(1):34. doi: 10.1186/s12910-016-0118-0.

38.

The current economic burden of illness of osteoporosis in Canada.

Hopkins RB, Burke N, Von Keyserlingk C, Leslie WD, Morin SN, Adachi JD, Papaioannou A, Bessette L, Brown JP, Pericleous L, Tarride J.

Osteoporos Int. 2016 Oct;27(10):3023-32. doi: 10.1007/s00198-016-3631-6. Epub 2016 May 11.

39.

A population-based analysis of the drivers of short-term costs after bariatric surgery within a publicly funded regionalized center of excellence system.

Doumouras AG, Saleh F, Tarride JE, Hong D.

Surg Obes Relat Dis. 2016 Jun;12(5):1023-1031. doi: 10.1016/j.soard.2016.02.016. Epub 2016 Feb 23.

PMID:
27150342
40.

Loss of health related quality of life following low-trauma fractures in the elderly.

Tarride JE, Burke N, Leslie WD, Morin SN, Adachi JD, Papaioannou A, Bessette L, Brown JP, Pericleous L, Muratov S, Hopkins RB.

BMC Geriatr. 2016 Apr 19;16:84. doi: 10.1186/s12877-016-0259-5.

41.

CYCLE pilot: a protocol for a pilot randomised study of early cycle ergometry versus routine physiotherapy in mechanically ventilated patients.

Kho ME, Molloy AJ, Clarke F, Herridge MS, Koo KK, Rudkowski J, Seely AJ, Pellizzari JR, Tarride JE, Mourtzakis M, Karachi T, Cook DJ; Canadian Critical Care Trials Group.

BMJ Open. 2016 Apr 8;6(4):e011659. doi: 10.1136/bmjopen-2016-011659.

42.

Bridging the Gap between Evidence and Practice for Adults with Medically Refractory Temporal Lobe Epilepsy: Is a Change in Funding Policy Needed to Stimulate a Shift in Practice?

Mansouri A, Aldakkan A, Kosicka MJ, Tarride JE, Valiante TA.

Epilepsy Res Treat. 2015;2015:675071. doi: 10.1155/2015/675071. Epub 2015 Dec 7. Review.

43.

Impact on health-related quality of life and costs of managing chronic neuropathic pain in academic pain centres: Results from a one-year prospective observational Canadian study.

Tarride JE, Moulin DE, Lynch M, Clark AJ, Stitt L, Gordon A, Morley-Forster PK, Nathan H, Smyth C, Toth C, Ware MA.

Pain Res Manag. 2015 Nov-Dec;20(6):327-33. Epub 2015 Oct 16.

44.

Barriers and facilitators influencing ethical evaluation in health technology assessment.

Assasi N, Schwartz L, Tarride JE, O'Reilly D, Goeree R.

Int J Technol Assess Health Care. 2015 Jan;31(3):113-23. doi: 10.1017/S026646231500032X.

PMID:
26179275
45.

Systematic narrative review of decision frameworks to select the appropriate modelling approaches for health economic evaluations.

Tsoi B, O'Reilly D, Jegathisawaran J, Tarride JE, Blackhouse G, Goeree R.

BMC Res Notes. 2015 Jun 17;8:244. doi: 10.1186/s13104-015-1202-0. Review.

46.

Do different decision-analytic modeling approaches produce different results? A systematic review of cross-validation studies.

Tsoi B, Goeree R, Jegathisawaran J, Tarride JE, Blackhouse G, O'Reilly D.

Expert Rev Pharmacoecon Outcomes Res. 2015 Jun;15(3):451-63. doi: 10.1586/14737167.2015.1021336. Epub 2015 Mar 2. Review.

PMID:
25728942
47.

Concomitant Use of Non-Steroidal Anti-Inflammatory Drugs (Nsaids) And Proton Pump Inhibitors (Ppis) in Newly Diagnosed Patients With Osteoarthritis (Oa), Rheumatoid Arthritis (Ra) or Ankylosing Spondylitis (As).

Dziarmaga A, Reidel K, White R, Tarride JE, Corner N.

Value Health. 2014 Nov;17(7):A390. doi: 10.1016/j.jval.2014.08.2666. Epub 2014 Oct 26. No abstract available.

48.
49.

Methodological guidance documents for evaluation of ethical considerations in health technology assessment: a systematic review.

Assasi N, Schwartz L, Tarride JE, Campbell K, Goeree R.

Expert Rev Pharmacoecon Outcomes Res. 2014 Apr;14(2):203-20. doi: 10.1586/14737167.2014.894464. Review.

PMID:
24625039
50.

Health utility scores in Alzheimer's disease: differences based on calculation with American and Canadian preference weights.

Oremus M, Tarride JE, Clayton N; Canadian Willingness-to-Pay Study Group, Raina P.

Value Health. 2014 Jan-Feb;17(1):77-83. doi: 10.1016/j.jval.2013.10.009.

Supplemental Content

Loading ...
Support Center